Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Mallika Rao explains that the true complexity ...

SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Generate Capital ("Generate"), a leading investor, owner and operator of critical infrastructure, today announced the closing of a $117 million term debt ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

{😸} Java and Kotlin Multiplatform library for generating JSON Schemas and LLM function schemas from Java and Kotlin classes and functions using Java annotation processing, reflection, KSP, or kotlinx ...

If you use Squarespace, you already know how easy it is to build a clean, professional website. But when it comes to SEO, many website owners stop after adding keywords and meta descriptions, missing ...

AI video generators help you turn your prompts into believable videos, complete with audio. We've tested all the top services to help you choose the one that does the best job with the fewest tweaks.

【免费下载链接】jsonschema2pojo Generate Java types from JSON or JSON Schema and annotate those types for data-binding with Jackson, Gson, etc 项目地址 ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...